Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05456191
Title A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (>=18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP) (ASC4START)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA | DEU

Facility Status City State Zip Country Details
Novartis Investigative Site Recruiting Buenos aires C1039AAC Argentina Details
Novartis Investigative Site Recruiting Pleven 5800 Bulgaria Details
Novartis Investigative Site Recruiting Plovdiv 4002 Bulgaria Details
Novartis Investigative Site Recruiting Sofia 1413 Bulgaria Details
Novartis Investigative Site Recruiting Sofia 1431 Bulgaria Details
Novartis Investigative Site Recruiting Sofia 1797 Bulgaria Details
Novartis Investigative Site Recruiting Varna 9010 Bulgaria Details
Novartis Investigative Site Recruiting Brno Bohunice Czech Republic 625 00 Czechia Details
Novartis Investigative Site Recruiting Praha 2 Czech Republic 128 20 Czechia Details
Novartis Investigative Site Recruiting Plzen-Bory 30599 Czechia Details
Novartis Investigative Site Recruiting Praha 10 100 34 Czechia Details
Novartis Investigative Site Recruiting Bordeaux 33076 France Details
Novartis Investigative Site Recruiting Caen Cedex 14033 France Details
Novartis Investigative Site Recruiting Clermont Ferrand 63003 France Details
Novartis Investigative Site Recruiting Lille Cedex 59037 France Details
Novartis Investigative Site Recruiting Lyon 69373 France Details
Novartis Investigative Site Recruiting Marseille 13273 France Details
Novartis Investigative Site Recruiting Nantes Cedex 1 44093 France Details
Novartis Investigative Site Recruiting Nice Cedex 06202 France Details
Novartis Investigative Site Recruiting Paris Cedex 10 75475 France Details
Novartis Investigative Site Recruiting Poitiers 86000 France Details
Novartis Investigative Site Recruiting Strasbourg 67200 France Details
Novartis Investigative Site Recruiting Toulouse 31059 France Details
Novartis Investigative Site Recruiting Vandoeuvre les Nancy cedex 54511 France Details
Novartis Investigative Site Recruiting Mannheim Baden-Wuerttemberg 68305 Germany Details
Novartis Investigative Site Recruiting Muenchen Bayern 81241 Germany Details
Novartis Investigative Site Recruiting Velbert North Rhine-Westphalia 42551 Germany Details
Novartis Investigative Site Recruiting Dresden Sachsen 01307 Germany Details
Novartis Investigative Site Recruiting Aachen 52074 Germany Details
Novartis Investigative Site Recruiting Bad Saarow 15526 Germany Details
Novartis Investigative Site Recruiting Bayreuth 95445 Germany Details
Novartis Investigative Site Recruiting Berlin 13353 Germany Details
Novartis Investigative Site Recruiting Bonn 53105 Germany Details
Novartis Investigative Site Recruiting Bremen 28177 Germany Details
Novartis Investigative Site Recruiting Chemnitz 09113 Germany Details
Novartis Investigative Site Recruiting Essen 45147 Germany Details
Novartis Investigative Site Recruiting Freiburg 79106 Germany Details
Novartis Investigative Site Recruiting Halle S 06120 Germany Details
Novartis Investigative Site Recruiting Hamburg 20246 Germany Details
Novartis Investigative Site Recruiting Hannover 30161 Germany Details
Novartis Investigative Site Recruiting Heidelberg 69120 Germany Details
Novartis Investigative Site Recruiting Jena 07740 Germany Details
Novartis Investigative Site Recruiting Leipzig 04103 Germany Details
Novartis Investigative Site Recruiting Magdeburg 39104 Germany Details
Novartis Investigative Site Recruiting Paderborn 33098 Germany Details
Novartis Investigative Site Recruiting Regensburg 93049 Germany Details
Novartis Investigative Site Recruiting Tübingen 72076 Germany Details
Novartis Investigative Site Recruiting Ulm 89081 Germany Details
Novartis Investigative Site Recruiting Ioannina GR 455 00 Greece Details
Novartis Investigative Site Recruiting Larissa GR 411 10 Greece Details
Novartis Investigative Site Recruiting Thessaloniki GR 570 10 Greece Details
Novartis Investigative Site Recruiting Athens 115 27 Greece Details
Novartis Investigative Site Recruiting Patras 265 00 Greece Details
Novartis Investigative Site Recruiting Budapest 1085 Hungary Details
Novartis Investigative Site Recruiting Budapest 1097 Hungary Details
Novartis Investigative Site Recruiting Eger 3300 Hungary Details
Novartis Investigative Site Recruiting Amman 11941 Jordan Details
Novartis Investigative Site Recruiting Bundang Gu Gyeonggi Do 13620 Korea, Republic of Details
Novartis Investigative Site Recruiting Uijeongbu si Gyeonggi Do 11759 Korea, Republic of Details
Novartis Investigative Site Recruiting Muscat 123 Oman Details
Novartis Investigative Site Recruiting Bucharest District 2 022328 Romania Details
Novartis Investigative Site Recruiting Tg Mures Mures 540136 Romania Details
Novartis Investigative Site Recruiting Bucharest 030 171 Romania Details
Novartis Investigative Site Recruiting Cluj-Napoca 400124 Romania Details
Novartis Investigative Site Recruiting Craiova 200136 Romania Details
Novartis Investigative Site Recruiting Sibiu 550245 Romania Details
Novartis Investigative Site Recruiting Timisoara 300079 Romania Details
Novartis Investigative Site Recruiting Singapore 119228 Singapore Details
Novartis Investigative Site Recruiting Singapore 169608 Singapore Details
Novartis Investigative Site Recruiting Singapore S308433 Singapore Details
Novartis Investigative Site Recruiting Kosice Slovak Republic 040 66 Slovakia Details
Novartis Investigative Site Recruiting Bratislava 85107 Slovakia Details
Novartis Investigative Site Recruiting Genève 1211 Switzerland Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field